Skip to main content
Top
Published in: Journal of Translational Medicine 1/2015

Open Access 01-12-2015 | Research

Establishment of a patient-derived orthotopic osteosarcoma mouse model

Authors: Claudia Blattmann, Markus Thiemann, Albrecht Stenzinger, Eva K Roth, Anne Dittmar, Hendrik Witt, Burkhard Lehner, Eva Renker, Manfred Jugold, Viktoria Eichwald, Wilko Weichert, Peter E Huber, Andreas E Kulozik

Published in: Journal of Translational Medicine | Issue 1/2015

Login to get access

Abstract

Background

Osteosarcoma (OS) is the most common pediatric primary malignant bone tumor. As the prognosis for patients following standard treatment did not improve for almost three decades, functional preclinical models that closely reflect important clinical cancer characteristics are urgently needed to develop and evaluate new treatment strategies. The objective of this study was to establish an orthotopic xenotransplanted mouse model using patient-derived tumor tissue.

Methods

Fresh tumor tissue from an adolescent female patient with osteosarcoma after relapse was surgically xenografted into the right tibia of 6 immunodeficient BALB/c Nu/Nu mice as well as cultured into medium. Tumor growth was serially assessed by palpation and with magnetic resonance imaging (MRI). In parallel, a primary cell line of the same tumor was established. Histology and high-resolution array-based comparative genomic hybridization (aCGH) were used to investigate both phenotypic and genotypic characteristics of different passages of human xenografts and the cell line compared to the tissue of origin.

Results

A primary OS cell line and a primary patient-derived orthotopic xenotranplanted mouse model were established. MRI analyses and histopathology demonstrated an identical architecture in the primary tumor and in the xenografts. Array-CGH analyses of the cell line and all xenografts showed highly comparable patterns of genomic progression. So far, three further primary patient-derived orthotopic xenotranplanted mouse models could be established.

Conclusion

We report the first orthotopic OS mouse model generated by transplantation of tumor fragments directly harvested from the patient. This model represents the morphologic and genomic identity of the primary tumor and provides a preclinical platform to evaluate new treatment strategies in OS.
Literature
1.
go back to reference Bielack SS, Kempf-Bielack B, Delling G, Exner BU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776–90.CrossRefPubMed Bielack SS, Kempf-Bielack B, Delling G, Exner BU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776–90.CrossRefPubMed
2.
go back to reference Langdon SP. Animal modeling of cancer pathology and studying tumor response to therapy. Curr Drug Targets. 2012;13(12):1535–47.CrossRefPubMed Langdon SP. Animal modeling of cancer pathology and studying tumor response to therapy. Curr Drug Targets. 2012;13(12):1535–47.CrossRefPubMed
4.
go back to reference Hiroshima Y, Zhang Y, Zhang N, Uehara F, Maawy A, Murakami T, et al. Patient-derived Orthotopic Xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model. Anticancer Res. 2015;35(2):697–701.PubMed Hiroshima Y, Zhang Y, Zhang N, Uehara F, Maawy A, Murakami T, et al. Patient-derived Orthotopic Xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model. Anticancer Res. 2015;35(2):697–701.PubMed
5.
go back to reference Brennecke P, Arlt MJ, Campanile C, Husmann K, Gvozdenovic A, Apuzzo T, et al. CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice. Clin Exp Metastasis. 2014;31(3):339–49.CrossRefPubMedCentralPubMed Brennecke P, Arlt MJ, Campanile C, Husmann K, Gvozdenovic A, Apuzzo T, et al. CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice. Clin Exp Metastasis. 2014;31(3):339–49.CrossRefPubMedCentralPubMed
6.
go back to reference Guijarro MV, Ghivizzani SC, Gibbs CP. Animal models in osteosarcoma. Front Oncol. 2014;4:182.CrossRef Guijarro MV, Ghivizzani SC, Gibbs CP. Animal models in osteosarcoma. Front Oncol. 2014;4:182.CrossRef
7.
go back to reference Crnalic S, Häkansson I, Boquist L, Löfvenberg R, Brostrom LA. A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice. Clin Exp Metastasis. 1997;15(2):164–72.CrossRefPubMed Crnalic S, Häkansson I, Boquist L, Löfvenberg R, Brostrom LA. A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice. Clin Exp Metastasis. 1997;15(2):164–72.CrossRefPubMed
8.
go back to reference Zhang Y, Ma Q, Liu T, Ke S, Jiang K, Wen Y, et al. Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms. J Cancer Res Clin Oncol. 2014;140(2):329–40.CrossRefPubMed Zhang Y, Ma Q, Liu T, Ke S, Jiang K, Wen Y, et al. Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms. J Cancer Res Clin Oncol. 2014;140(2):329–40.CrossRefPubMed
9.
go back to reference Chan LH, Wang W, Yeung W, Deng Y, Yuan P, Mak KK. Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression. Oncogene. 2013;33(40):4857–66.CrossRefPubMed Chan LH, Wang W, Yeung W, Deng Y, Yuan P, Mak KK. Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression. Oncogene. 2013;33(40):4857–66.CrossRefPubMed
10.
go back to reference Brennecke P, Arlt MJ, Muff R, Campanile C, Gvozdenovic A, Husmann K, et al. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice. PLoS One. 2013;8(9):e74045.CrossRefPubMedCentralPubMed Brennecke P, Arlt MJ, Muff R, Campanile C, Gvozdenovic A, Husmann K, et al. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice. PLoS One. 2013;8(9):e74045.CrossRefPubMedCentralPubMed
11.
go back to reference Fletcher CDM, Bridge J A, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone. Volume 5. 4th ed. WHO Press. Fletcher CDM, Bridge J A, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone. Volume 5. 4th ed. WHO Press.
13.
go back to reference Solinas-Toldo S, Dürst M, Lichter P. Specific chromosomal imbalances in human papillomavirus-transfected cells during progression towardimmortality. Proc Natl Acad Sci U S A. 1997;94(8):3854–9.CrossRefPubMedCentralPubMed Solinas-Toldo S, Dürst M, Lichter P. Specific chromosomal imbalances in human papillomavirus-transfected cells during progression towardimmortality. Proc Natl Acad Sci U S A. 1997;94(8):3854–9.CrossRefPubMedCentralPubMed
14.
go back to reference Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, et al. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer. 2005;43(3):294–301.CrossRefPubMed Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, et al. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer. 2005;43(3):294–301.CrossRefPubMed
15.
go back to reference Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Döhner H, et al. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes, Chromosomes Cancer. 1997;20:399–407.CrossRefPubMed Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Döhner H, et al. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes, Chromosomes Cancer. 1997;20:399–407.CrossRefPubMed
16.
go back to reference Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, et al. Outcome prediction in pediatric medulloblastoma based on dna copy-number aberrations of chromosomes 6q and 17q and the myc and mycn loci. J Clin Oncol. 2009;27(10):1627–36.CrossRefPubMed Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, et al. Outcome prediction in pediatric medulloblastoma based on dna copy-number aberrations of chromosomes 6q and 17q and the myc and mycn loci. J Clin Oncol. 2009;27(10):1627–36.CrossRefPubMed
18.
go back to reference Salzer-Kuntschik M, Brand G, Delling G. Bestimmung des morphologischen regressionsgrades nach chemotherapie bei malignen knochentumoren. Pathologie. 1983;4:135–41. Salzer-Kuntschik M, Brand G, Delling G. Bestimmung des morphologischen regressionsgrades nach chemotherapie bei malignen knochentumoren. Pathologie. 1983;4:135–41.
19.
go back to reference Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, et al. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004;4:45.CrossRefPubMedCentralPubMed Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, et al. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004;4:45.CrossRefPubMedCentralPubMed
20.
go back to reference Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev. 2014;40(4):523–32.CrossRefPubMed Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev. 2014;40(4):523–32.CrossRefPubMed
21.
go back to reference Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009;28(1–2):247–63.CrossRefPubMed Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009;28(1–2):247–63.CrossRefPubMed
22.
go back to reference Blattmann C, Thiemann M, Stenzinger A, Christmann A, Roth E, Ehemann V, et al. Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model. Strahlenther Onkol. 2013;189(11):957–66.CrossRefPubMed Blattmann C, Thiemann M, Stenzinger A, Christmann A, Roth E, Ehemann V, et al. Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model. Strahlenther Onkol. 2013;189(11):957–66.CrossRefPubMed
23.
go back to reference Pignochino Y, Dell’Aglio C, Basiricò M, Capozzi F, Soster M, Marchiò S, et al. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models. Clin Cancer Res. 2013;19(8):2117–31.CrossRefPubMed Pignochino Y, Dell’Aglio C, Basiricò M, Capozzi F, Soster M, Marchiò S, et al. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models. Clin Cancer Res. 2013;19(8):2117–31.CrossRefPubMed
24.
go back to reference Chaffee BK, Allen MJ. A clinically relevant mouse model of canine osteosarcoma with spontaneous metastasis. In Vivo. 2013;27(5):599–603.PubMedCentralPubMed Chaffee BK, Allen MJ. A clinically relevant mouse model of canine osteosarcoma with spontaneous metastasis. In Vivo. 2013;27(5):599–603.PubMedCentralPubMed
25.
go back to reference Rao-Bindal K, Rao CK, Yu L, Kleinerman ES. Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts. Pediatr Blood Cancer. 2013;60(4):575–9.CrossRefPubMed Rao-Bindal K, Rao CK, Yu L, Kleinerman ES. Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts. Pediatr Blood Cancer. 2013;60(4):575–9.CrossRefPubMed
26.
go back to reference Cole HA, Ohba T, Ichikawa J, Nyman JS, Cates JM, Haro H, et al. Micro-Computed Tomography Derived Anisotropy Detects Tumor Provoked Deviations in Bone in an Orthotopic Osteosarcoma Murine Model. PLoS One. 2014;9(6):e97381.CrossRefPubMedCentralPubMed Cole HA, Ohba T, Ichikawa J, Nyman JS, Cates JM, Haro H, et al. Micro-Computed Tomography Derived Anisotropy Detects Tumor Provoked Deviations in Bone in an Orthotopic Osteosarcoma Murine Model. PLoS One. 2014;9(6):e97381.CrossRefPubMedCentralPubMed
27.
go back to reference Vormoor B, Knizia HK, Batey MA, Almeida G, Wilson I, Dildey P, et al. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging. PLoS One. 2014;9(1), e85128.CrossRefPubMedCentralPubMed Vormoor B, Knizia HK, Batey MA, Almeida G, Wilson I, Dildey P, et al. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging. PLoS One. 2014;9(1), e85128.CrossRefPubMedCentralPubMed
28.
go back to reference Folkvord S, Ree AH, Furre T, Halvorsen T, Flatmark K. Radiosensitization by SAHA in experimental colorectal carcinoma models—in vivo effects and relevance of histone acetylation status. Int J Radiat Oncol Biol Phys. 2009;74:546–52.CrossRefPubMed Folkvord S, Ree AH, Furre T, Halvorsen T, Flatmark K. Radiosensitization by SAHA in experimental colorectal carcinoma models—in vivo effects and relevance of histone acetylation status. Int J Radiat Oncol Biol Phys. 2009;74:546–52.CrossRefPubMed
29.
go back to reference Sicklick JK, Leonard SY, Babicky ML, Tang C-M, Mose ES, French RP, et al. Generation of orthotopic patient-derived xenografts from gatsrointestinal stromal tumor. J Transl Med. 2014;12:41.CrossRefPubMedCentralPubMed Sicklick JK, Leonard SY, Babicky ML, Tang C-M, Mose ES, French RP, et al. Generation of orthotopic patient-derived xenografts from gatsrointestinal stromal tumor. J Transl Med. 2014;12:41.CrossRefPubMedCentralPubMed
30.
go back to reference Wong NC, Bhadri VA, Maksimovic J, Parkinson-Bates M, Ng J, Craig JM, et al. Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance. BMC Genomics. 2014;15:416.CrossRefPubMedCentralPubMed Wong NC, Bhadri VA, Maksimovic J, Parkinson-Bates M, Ng J, Craig JM, et al. Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance. BMC Genomics. 2014;15:416.CrossRefPubMedCentralPubMed
31.
go back to reference Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, et al. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition. Breast Cancer Res. 2014;16(2):R36.CrossRefPubMedCentralPubMed Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, et al. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition. Breast Cancer Res. 2014;16(2):R36.CrossRefPubMedCentralPubMed
32.
go back to reference Wagner AJ. Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy-ready for prime time? Cancer. 2014;120(13):1917–9.CrossRefPubMed Wagner AJ. Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy-ready for prime time? Cancer. 2014;120(13):1917–9.CrossRefPubMed
33.
go back to reference Stebbing J, Paz K, Schwartz GK, Wexler LH, Maki R, Pollock RE, et al. Patient-derived xenografts for individualized care in advanced sarcoma. Cancer. 2014;120(13):2006–15.CrossRefPubMedCentralPubMed Stebbing J, Paz K, Schwartz GK, Wexler LH, Maki R, Pollock RE, et al. Patient-derived xenografts for individualized care in advanced sarcoma. Cancer. 2014;120(13):2006–15.CrossRefPubMedCentralPubMed
34.
go back to reference Blattmann C, Oertel S, Thiemann M, Weber KJ, Schmezer P, Zelezny O, et al. Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation. Strahlenther Onkol. 2012;188(2):168–76.CrossRefPubMed Blattmann C, Oertel S, Thiemann M, Weber KJ, Schmezer P, Zelezny O, et al. Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation. Strahlenther Onkol. 2012;188(2):168–76.CrossRefPubMed
35.
go back to reference Oertel S, Thiemann M, Richter K, Weber KJ, Huber PE, Perez RL, et al. Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines. Radiat Oncol. 2011;6:119.CrossRefPubMedCentralPubMed Oertel S, Thiemann M, Richter K, Weber KJ, Huber PE, Perez RL, et al. Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines. Radiat Oncol. 2011;6:119.CrossRefPubMedCentralPubMed
Metadata
Title
Establishment of a patient-derived orthotopic osteosarcoma mouse model
Authors
Claudia Blattmann
Markus Thiemann
Albrecht Stenzinger
Eva K Roth
Anne Dittmar
Hendrik Witt
Burkhard Lehner
Eva Renker
Manfred Jugold
Viktoria Eichwald
Wilko Weichert
Peter E Huber
Andreas E Kulozik
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2015
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-015-0497-x

Other articles of this Issue 1/2015

Journal of Translational Medicine 1/2015 Go to the issue